What are the normal fibrinogen concentrations in mg/dL during the second and third trimesters of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Fibrinogen Concentrations in Second and Third Trimester of Pregnancy

Normal fibrinogen levels in the second trimester range from 340–850 mg/dL (3.4–8.5 g/L), and in the third trimester from 370–620 mg/dL (3.7–6.2 g/L), with a median of approximately 386 mg/dL at 36 weeks gestation. 1

Physiologic Elevation Throughout Pregnancy

  • Fibrinogen rises progressively from the first trimester and continues to increase throughout gestation, reflecting heightened coagulation factor production as term approaches 1

  • This elevation represents a normal hypercoagulable adaptation that protects against postpartum hemorrhage rather than indicating pathology 1

  • Mean fibrinogen levels exceed the conventional non-pregnant reference interval as early as the 16th week of pregnancy 2

Trimester-Specific Reference Ranges

Second Trimester (13–24 weeks)

  • Reference range: 340–850 mg/dL (3.4–8.5 g/L) 1
  • Mean levels in uncomplicated pregnancies: approximately 404 mg/dL (4.04 g/L) 3
  • Alternative reported range: 260–656 mg/dL (2.60–6.56 g/L) in early-to-mid pregnancy 4

Third Trimester (25–42 weeks)

  • Reference range: 370–620 mg/dL (3.7–6.2 g/L) 1
  • Median at 36 weeks: 386 mg/dL (3.86 g/L) 5, 1
  • Mean levels in uncomplicated pregnancies: approximately 440 mg/dL (4.40 g/L) 3
  • Alternative reported range: 363–914 mg/dL (3.63–9.14 g/L) 4

Clinical Interpretation Thresholds

Pathologically Low Levels

  • Fibrinogen < 300 mg/dL (< 3 g/L) is a key criterion in pregnancy-specific disseminated intravascular coagulation (DIC) scoring systems 5, 1

  • Fibrinogen ≤ 200 mg/dL (≤ 2 g/L) has a 100% positive predictive value for severe postpartum hemorrhage 5, 1

  • Fibrinogen < 150 mg/dL (< 1.5 g/L) in the second trimester warrants fibrinogen replacement therapy in women with congenital hypofibrinogenemia to prevent placental abruption 5, 1

Target Levels for High-Risk Conditions

  • Women with congenital fibrinogen disorders should maintain trough levels ≥ 100 mg/dL (≥ 1 g/L) throughout pregnancy, or 50–100 mg/dL (0.5–1 g/L) during the first two trimesters if higher targets are difficult to achieve 5

  • In cases of vaginal bleeding or placental abruption, target fibrinogen levels should be increased to ≥ 150 mg/dL (≥ 1.5 g/L) 5

Important Clinical Caveats

  • Elevated fibrinogen in pregnancy denotes normal physiology and increased thrombotic risk—it does not signify bleeding risk 1

  • Only critically low fibrinogen levels (approximately < 150–200 mg/dL) are predictive of hemorrhagic complications 1

  • The percentage of high molecular weight fibrinogen remains unaltered during normal pregnancy despite the increase in total fibrinogen concentration 6

  • Women with pregnancy-related complications show significantly higher mean fibrinogen levels throughout gestation, except in placental abruption where levels decrease from the third trimester and may fall below those of uncomplicated pregnancies 3

  • Gestational diabetes mellitus (GDM) is associated with significantly higher fibrinogen concentrations compared to uncomplicated pregnancies 4

budget:token_budget Tokens used this turn: 4857 Total tokens used: 4857 Tokens remaining: 195143

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.